Basic information Safety Supplier Related

1-(BETA-D-Xylofuranosyl)-5-methylcytosine

Basic information Safety Supplier Related

1-(BETA-D-Xylofuranosyl)-5-methylcytosine Basic information

Product Name:
1-(BETA-D-Xylofuranosyl)-5-methylcytosine
Synonyms:
  • 1-(BETA-D-Xylofuranosyl)-5-methylcytosine
  • 5-Methyl-xylo-cytidine
  • 1-(b-D-Xylofuranosyl)-5-methylcytosine
  • 2(1H)-Pyrimidinone, 4-amino-5-methyl-1-β-D-xylofuranosyl-
  • 4-amino-1-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one
CAS:
18492-10-9
MF:
C10H15N3O5
MW:
257.2432
Mol File:
18492-10-9.mol
More
Less

1-(BETA-D-Xylofuranosyl)-5-methylcytosine Chemical Properties

Melting point:
205-207 °C(Solv: ethanol (64-17-5))
Boiling point:
537.5±60.0 °C(Predicted)
Density 
1.79±0.1 g/cm3(Predicted)
pka
13.48±0.70(Predicted)
More
Less

1-(BETA-D-Xylofuranosyl)-5-methylcytosine Usage And Synthesis

Uses

1-(β-D-Xylofuranosyl)-5-methylcytosine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].

References

[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
[2] Gowher H, et al. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy. Cancer Biol Ther. 2004 Nov;3(11):1062-8. DOI:10.4161/cbt.3.11.1308

1-(BETA-D-Xylofuranosyl)-5-methylcytosineSupplier

Zhengzhou Granlen Sciences, ltd.
Tel
0371-85513397 +86-18610099868
Email
info@granlen.com
BOC Sciences
Tel
16314854226; +16314854226
Email
inquiry@bocsci.com
NewCan Biotech Limited
Tel
+86-0571-86912261 +8613735419629
Email
sales@newcanbio.com
Amel Pharmatech Corporation
Tel
027-888-4366503
Email
sales@amelpharmatech.com
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
Tel
+86-021-61551413 +8618813727289
Email
contact@trustwe.com